ID   C418-59
AC   CVCL_DC73
SY   418-59
DR   Wikidata; Q54808181
RX   Patent=US5024946;
RX   PubMed=2470715;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85071031.
CC   Doubling time: 20 hours (PubMed=2470715).
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a gastric cancer.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
RX   Patent=US5024946;
RA   Abe T., Fukumoto M.;
RT   "Human monoclonal antibody to antigen of gastric cancer and B-cell
RT   line for producing this antibody, method for preparing this B-cell
RT   line and antibody, antigen and method of preparation of this
RT   antigen.";
RL   Patent number US5024946, 18-Jun-1991.
//
RX   PubMed=2470715; DOI=10.1111/j.1349-7006.1989.tb02304.x;
RA   Abe T., Fukumoto M., Tsuchiya K., Kuramochi K., Furuta T., Togoh S.,
RA   Nishiyama K., Tsuchiya S.;
RT   "Human monoclonal antibodies against cytokeratin 18 generated from
RT   patients with gastric cancer.";
RL   Jpn. J. Cancer Res. 80:271-276(1989).
//